Do Topical Treatments Help Folliculitis Decalvans Flares?
At a Glance
Medicated shampoos, topical antibiotics, and steroid injections can calm localized inflammation and pustules in folliculitis decalvans, but they usually work as add-on treatments. They do not cure the condition or regrow hair from follicles permanently damaged by scarring.
In this answer
6 sections
Yes, medicated shampoos, topical antibiotics, and steroid injections are used to treat Quinquaud folliculitis decalvans (FD). However, they are typically used as adjuncts (add-on therapies) to support oral medications, rather than as standalone treatments [1].
FD is a chronic inflammatory scarring condition, not simply a bacterial infection or a hygiene issue [1][2]. The goal of treatment is to quiet active inflammation, reduce pustules (small pus-filled bumps), and try to preserve remaining hair follicles [3][4].
What Local Treatments Can and Cannot Do
- Can Do: Reduce active swelling and redness, manage localized pustules, soften crusts, and help prevent further hair loss [3][4].
- Cannot Do: Cure the underlying condition or regrow hair from follicles that have been permanently replaced by scar tissue [1][5]. (Camouflage techniques, hairpieces, or hair transplantation may be options to discuss, but only after the disease has been inactive for a prolonged period [1][6]).
Antiseptic Scalp Washes
Antimicrobial and antiseptic scalp washes are sometimes included in an individualized FD treatment plan to help manage the scalp environment [3].
- Role: These clinician-directed washes can help soften and remove crusts and reduce the surface bacteria that may aggravate the condition [3][7]. (Note: Never use household disinfectants on your skin).
- Practical Use: Use these products exactly as directed by your clinician. They will specify how often to use them and how long to leave them on. Avoid getting them in your eyes, and do not vigorously scrub or pick at crusts, as this can worsen inflammation [3].
- Limitations and Risks: Antiseptics do not cure the underlying inflammation [8]. They can also cause dryness, irritation, or allergic reactions. If you experience significant burning, rash, or worsening symptoms, stop using the wash and contact your doctor [8].
Topical Antibiotics
Topical antibiotics (such as fusidic acid or clindamycin applied directly to the scalp) are sometimes used as an add-on therapy [9]. While Staphylococcus aureus bacteria may be present and contribute to FD flares, they are not the sole cause of the condition [7].
- Role: Topical antibiotics can help manage small, localized outbreaks of pustules or reduce surface bacteria [9].
- Important Cautions: Using topical antibiotics for long periods increases the risk of antibiotic resistance—where unnecessary or prolonged exposure selects for bacteria that no longer respond to the medication [10]. Because new pustules or worsening hair loss could mean the disease is active, irritated, or resistant, patients cannot diagnose resistance themselves. Use these medications only for the prescribed time and on the specific affected areas, and contact your doctor if lesions persist or worsen [10][7].
Corticosteroids: Topical and Injected
Corticosteroids (strong anti-inflammatory medications) can be applied as lotions or injected to rapidly bring down swelling, redness, and pain [1].
- Intralesional Injections: Injecting a steroid directly into an active, affected area (intralesional) can help calm localized inflammation [4]. However, injections do not guarantee a durable remission or reverse scarring, and they may need to be carefully spaced out over time.
- Side Effects: Repeated or prolonged use can cause skin atrophy (thinning of the skin) or lipoatrophy (loss of underlying fat), creating a sunken appearance [11]. They can also cause telangiectasia (prominent, visible blood vessels) and permanent or temporary changes in skin color [12][13]. Contact your doctor if you notice marked indentation, pain, drainage, or unexpected changes [11]. Always use topical steroids exactly as prescribed.
When Systemic Therapy is Considered
If you have multiple active patches, widespread inflammation, or a progressing area of hair loss, your dermatologist may consider systemic therapy (medications taken by mouth that work throughout the body) [1][2]. These often include oral antibiotics (like a combination of clindamycin and rifampicin, or tetracyclines) or oral isotretinoin [1][4]. The goal is to reduce active inflammation, though responses vary and relapses are common [8].
Safety Context for Systemic Drugs:
These medications require careful prescriber supervision, and they are not interchangeable [1].
- Clindamycin carries a risk of severe antibiotic-associated diarrhea.
- Rifampicin has major drug interactions and can make hormonal contraception unreliable.
- Tetracyclines can cause sun sensitivity and are restricted by age and during pregnancy.
- Isotretinoin requires strict pregnancy prevention measures and regular laboratory monitoring [4][1].
Review all medicines, supplements, and pregnancy plans with your prescriber.
When to Contact Your Doctor
Early control of inflammation helps limit additional permanent scarring.
- Prompt Review: Contact your dermatologist for an appointment if you notice new or spreading bald patches, persistent pustules, or if your current routine is causing irritation [2].
- Urgent Care: Seek urgent medical care for signs of severe infection or a severe reaction, such as a fever, rapidly spreading redness, severe pain, drainage, or feeling systemically unwell [7].
Common questions in this guide
Can local scalp treatments cure folliculitis decalvans?
What do medicated shampoos do for folliculitis decalvans?
Are topical antibiotics useful for folliculitis decalvans pustules?
Can steroid injections calm an active folliculitis decalvans flare?
When might oral treatment be needed for folliculitis decalvans?
When should I contact a doctor about worsening folliculitis decalvans?
Related questions
Show more
Get notified when new evidence is published on Quinquaud folliculitis decalvans.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Management of folliculitis decalvans: The EADV task force on hair diseases position statement.
Waśkiel-Burnat A, Starace M, Iorizzo M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.
PMID: 40230058 - 2
Folliculitis decalvans: a multicentre review of 82 patients.
Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.
PMID: 25682915 - 3
Treatment Survival and Reasons for Discontinuation in Patients with Recalcitrant Folliculitis Decalvans.
Farnina L, Cazzaniga S, Hunger RE, et al.
Acta dermato-venereologica 2025; (105()):adv44185 doi:10.2340/actadv.v105.44185.
PMID: 41211948 - 4
Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.
Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al.
Journal of the American Academy of Dermatology 2018; (79(5)):878-883 doi:10.1016/j.jaad.2018.05.1240.
PMID: 29864465 - 5
Primary scarring alopecias.
Rigopoulos D, Stamatios G, Ioannides D
Current problems in dermatology 2015; (47()):76-86 doi:10.1159/000369407.
PMID: 26370646 - 6
A Systematic Review of Follicular Unit Graft Survival Rates After Hair Transplantation in Primary Cicatricial Alopecia.
Yii V, Moussa A, Triwongwaranat D, et al.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2025; (51(11)):1052-1057 doi:10.1097/DSS.0000000000004707.
PMID: 40439233 - 7
Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota.
Matard B, Donay JL, Resche-Rigon M, et al.
Experimental dermatology 2020; (29(3)):295-298 doi:10.1111/exd.13916.
PMID: 30907453 - 8
Management of Folliculitis Decalvans: A Systematic Review.
Sideris E, Xie D, du Plessis J, de Zwaan S
The Australasian journal of dermatology 2025; (66(8)):448-461 doi:10.1111/ajd.14603.
PMID: 41146582 - 9
Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.
Pimenta R, Borges-Costa J
Acta dermatovenerologica Croatica : ADC 2019; (27(1)):49-50.
PMID: 31032795 - 10
Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients.
Tietze JK, Heppt MV, von Preußen A, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1816-21 doi:10.1111/jdv.13052.
PMID: 25712452 - 11
Delineating Injectable Triamcinolone-Induced Cutaneous Atrophy and Therapeutic Options in 24 Patients-A Retrospective Study.
Sharma RK, Gupta M, Rani R
Indian dermatology online journal 2022; (13(2)):199-206 doi:10.4103/idoj.idoj_483_21.
PMID: 35287395 - 12
Trichoscopy of Steroid-Induced Atrophy.
Pirmez R, Abraham LS, Duque-Estrada B, et al.
Skin appendage disorders 2017; (3(4)):171-174 doi:10.1159/000471771.
PMID: 29177140 - 13
Linear Leucoderma Following Intralesional Steroid Injection.
Beena A, Sapam R, Devi GC, et al.
Cureus 2024; (16(5)):e60783 doi:10.7759/cureus.60783.
PMID: 38903338
This page is for informational purposes only and does not constitute medical advice. Your dermatologist should choose and monitor treatment for folliculitis decalvans, including whether oral therapy is needed.